Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Flavio Malcher Martins De Oliveira

Surgery New York, NY Medical Doctor

NPI 1548767908 CMS profile 5130991

530 1St Ave, New York, NY 10016

Open in the dashboard

General payments

$694,955

924 records reported · program years 2019–2025

Research payments

$3,660

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$119,073 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Flavio Malcher Martins De Oliveira of New York, NY is reported in the CMS Open Payments database as having received $694,955 across 924 general payments and $3,660 in research payments paid to them. Separately, studies naming them as principal investigator received $119,073 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $120,720 176
2025 Research $3,660 2
2024 General $123,520 184
2023 General $78,106 89
2022 General $68,675 128
2021 General $65,748 93
2020 General $129,130 124
2019 General $109,056 130

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Flavio Malcher Martins De Oliveira
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Flavio Malcher Martins De Oliveira were reported at $120,720. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Flavio Malcher Martins De Oliveira Surgery median Middle half National median
2019 $109,056 $253 $82–$1,521 $163
2020 $129,130 $131 $40–$706 $114
2021 $65,748 $168 $50–$904 $132
2022 $68,675 $224 $76–$1,218 $149
2023 $78,106 $253 $82–$1,255 $160
2024 $123,520 $279 $90–$1,381 $164
2025 $120,720 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Davol Inc. $341,388 291 payments
  2. Intuitive Surgical, Inc. $173,266 243 payments
  3. Medtronic, Inc. $68,371 100 payments
  4. Covidien LP $31,692 46 payments
  5. Integra LifeSciences Corporation $31,278 51 payments
  6. W. L. Gore & Associates, Inc. $13,684 64 payments
  7. Surgical Specialties Corporation (US), Inc. $5,784 5 payments
  8. Vertex Pharmaceuticals Incorporated $4,794 11 payments
  9. Origami Surgical Inc $4,500 4 payments
  10. Allergan Inc. $4,231 5 payments
  11. Other $15,966 104 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $268,820 129 payments
  2. Consulting Fee $152,725 81 payments
  3. Education $117,866 53 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64,047 36 payments
  5. Travel and Lodging $61,828 194 payments
  6. Food and Beverage $29,661 430 payments
  7. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $169,016 238 payments
  2. ProGrip Hernia Repair $16,791 16 payments
  3. ProGrip Hernia Repair $12,652 18 payments
  4. Phasix Mesh $11,902 40 payments
  5. PRIMATRIX $11,193 23 payments
  6. GORE ENFORM Intraperitoneal Biomaterial $10,703 8 payments
  7. Integra Recon-Skin And Wound $9,839 22 payments
  8. Integra Recon-Skin And Wound $9,839 22 payments
  9. GORE SYNECOR Biomaterial $9,573 28 payments
  10. ADVANCED WOUND CARE $8,790 9 payments
  11. Other $94,797 308 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $3,600 1 payment
  2. AbbVie, Inc. $60 1 payment

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$98,407

Medicare's payments for the services billed

Medicare patients

189

Average age 73

Services billed

355

69 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 52%
Ischemic heart disease 41%
Diabetes 36%
Cancer 30%
Chronic kidney disease 28%
Depression 25%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

926 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record